SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000944809-22-000038
Filing Date
2022-08-04
Accepted
2022-08-04 16:27:05
Documents
88
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q opk-20220630.htm   iXBRL 10-Q 2666298
2 EX-31.1 opk-6302022xex311.htm EX-31.1 9413
3 EX-31.2 opk-6302022xex312.htm EX-31.2 9390
4 EX-32.1 opk-6302022xex321.htm EX-32.1 3690
5 EX-32.2 opk-6302022xex322.htm EX-32.2 3723
  Complete submission text file 0000944809-22-000038.txt   13202587

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT opk-20220630.xsd EX-101.SCH 80022
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT opk-20220630_cal.xml EX-101.CAL 106433
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT opk-20220630_def.xml EX-101.DEF 525018
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT opk-20220630_lab.xml EX-101.LAB 1012481
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT opk-20220630_pre.xml EX-101.PRE 711155
82 EXTRACTED XBRL INSTANCE DOCUMENT opk-20220630_htm.xml XML 2502428
Mailing Address 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. MIAMI FL 33137 305-575-4181
OPKO HEALTH, INC. (Filer) CIK: 0000944809 (see all company filings)

IRS No.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33528 | Film No.: 221137052
SIC: 2834 Pharmaceutical Preparations